Aardvark Therapeutics, Inc.
AARD
$11.75
-$0.064-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -6.05% | -109.92% | -6.71% | ||
| Total Depreciation and Amortization | 104.13% | -239.08% | 102.78% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -23.46% | 51.69% | 15.97% | ||
| Change in Net Operating Assets | -389.20% | 948.96% | -145.97% | ||
| Cash from Operations | -47.38% | -95.37% | -89.45% | ||
| Capital Expenditure | -- | -20.00% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -847.30% | -- | -- | ||
| Cash from Investing | -846.82% | -237,800.00% | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 55,841.72% | -3.55% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -96.26% | -1,020.95% | -- | ||
| Cash from Financing | 8,864.79% | -1,684.38% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -70.27% | -429.67% | -89.88% | ||